Rare diseases
Investigational molecules
Locations
279 conditions with trials, the busiest first
686 trials across Europe, recruiting first
CzechiaA Study of Brelovitug Compared to Delayed Treatment in Patients with Chronic Hepatitis Delta Infection
BelgiumA study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia
AustriaStudy of GSK3965193 and Bepirovirsen for People Living with Chronic Hepatitis B Infection and Healthy Participants
FranceA study of immune system response in adults who develop shingles after receiving recombinant herpes zoster vaccine to understand vaccine protection
BelgiumA Study Testing mRNA-1273 Vaccine Safety and Effectiveness Against Severe COVID-19 in Adults Aged 50-64 Years Without Risk Factors
DenmarkA Study to Test the Safety and Body's Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years
BelgiumA study to test the safety and immune response of PHH-1V111 vaccine against COVID-19 variants in adults
SpainStudy of mRNA-based seasonal influenza vaccine to evaluate immune response and safety in adults 18 years and older
BelgiumStudy of H5N8 influenza vaccine in adults previously vaccinated with H5N1/MF59 vaccine compared to those never vaccinated with H5 vaccine
BelgiumStudy of Rezafungin in Blood and Peritoneal Fluid for Patients with Suspected Intra-Abdominal Candidiasis
SpainComparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease
BulgariaThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
